BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 33995809)

  • 1. Prevalence of rifampicin resistance tuberculosis among HIV/TB coinfected patients in Benue State, Nigeria.
    Ejeh FE; Undiandeye A; Okon K; Moshood KH
    Pan Afr Med J; 2021; 38():203. PubMed ID: 33995809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and Immunological Detection of
    Ejeh FE; Undiandeye A; Okon K; Kazeem HM; Kudi AC
    Ethiop J Health Sci; 2020 Jan; 30(1):55-64. PubMed ID: 32116433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GeneXpert
    Christopher PM; ; Widysanto A
    Int J Mycobacteriol; 2019; 8(4):351-358. PubMed ID: 31793505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smear positive pulmonary tuberculosis and associated factors among homeless individuals in Dessie and Debre Birhan towns, Northeast Ethiopia.
    Semunigus T; Tessema B; Eshetie S; Moges F
    Ann Clin Microbiol Antimicrob; 2016 Aug; 15(1):50. PubMed ID: 27581729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidrug-resistant tuberculosis in Imo State, Southeast, Nigeria.
    E Ahiarakwem II; Ekejindu IM; Akujobi CN; Aghanya IN
    Niger J Clin Pract; 2020 Aug; 23(8):1172-1177. PubMed ID: 32788498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study.
    Scott LE; McCarthy K; Gous N; Nduna M; Van Rie A; Sanne I; Venter WF; Duse A; Stevens W
    PLoS Med; 2011 Jul; 8(7):e1001061. PubMed ID: 21814495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of Multi-Drug Resistant Tuberculosis among Tuberculosis Patients Attending Chest Clinics in Osun-State, Nigeria.
    Oyedeji GJ; Adeyemo C; Dissou A; Abiodun T; Alli OAT; Onaolapo OJ; Onaolapo AY; Adesiji Y; Olowe OA
    Curr Pharm Biotechnol; 2020; 21(10):939-947. PubMed ID: 32101120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rifampicin mono-resistance in Mycobacterium tuberculosis in KwaZulu-Natal, South Africa: a significant phenomenon in a high prevalence TB-HIV region.
    Coovadia YM; Mahomed S; Pillay M; Werner L; Mlisana K
    PLoS One; 2013; 8(11):e77712. PubMed ID: 24223122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of tuberculosis treatment success among HIV-TB co-infected patients attending major tuberculosis treatment sites in Abeokuta, Ogun State, Nigeria.
    Akanbi K; Ajayi I; Fayemiwo S; Gidado S; Oladimeji A; Nsubuga P
    Pan Afr Med J; 2019; 32(Suppl 1):7. PubMed ID: 30984328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidrug- and isoniazid-resistant tuberculosis in three high HIV burden African regions.
    Sanchez-Padilla E; Ardizzoni E; Sauvageot D; Ahoua L; Martin A; Varaine F; Adatu-Engwau F; Akeche G; Salaniponi F; Bonnet M
    Int J Tuberc Lung Dis; 2013 Aug; 17(8):1036-42. PubMed ID: 23827027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of rifampicin resistant tuberculosis and associated factors among presumptive tuberculosis patients in a secondary referral hospital in Lagos Nigeria.
    Adejumo OA; Olusola-Faleye B; Adepoju V; Bowale A; Adesola S; Falana A; Owuna H; Otemuyiwa K; Oladega S; Adegboye O
    Afr Health Sci; 2018 Sep; 18(3):472-478. PubMed ID: 30602977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-resistance patterns of Mycobacterium tuberculosis strains and associated risk factors among multi drug-resistant tuberculosis suspected patients from Ethiopia.
    Mesfin EA; Beyene D; Tesfaye A; Admasu A; Addise D; Amare M; Dagne B; Yaregal Z; Tesfaye E; Tessema B
    PLoS One; 2018; 13(6):e0197737. PubMed ID: 29864118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-resistant TB prevalence study in 5 health institutions in Haiti.
    Hoffmann J; Chedid C; Ocheretina O; Masetti C; Joseph P; Mabou MM; Mathon JE; Francois EM; Gebelin J; Babin FX; Raskine L; Pape JW
    PLoS One; 2021; 16(3):e0248707. PubMed ID: 33735224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of multidrug resistance in Mycobacterium tuberculosis isolates from HIV seropositive and seronegative patients with pulmonary tuberculosis in north India.
    Sethi S; Mewara A; Dhatwalia SK; Singh H; Yadav R; Singh K; Gupta D; Wanchu A; Sharma M
    BMC Infect Dis; 2013 Mar; 13():137. PubMed ID: 23497169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-Life Clinical Practice of Using the Xpert MTB/RIF Assay in Thailand.
    Kawkitinarong K; Suwanpimolkul G; Kateruttanakul P; Manosuthi W; Ubolyam S; Sophonphan J; Avihingsanon A; Ruxrungtham K
    Clin Infect Dis; 2017 May; 64(suppl_2):S171-S178. PubMed ID: 28475796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting.
    Theron G; Peter J; van Zyl-Smit R; Mishra H; Streicher E; Murray S; Dawson R; Whitelaw A; Hoelscher M; Sharma S; Pai M; Warren R; Dheda K
    Am J Respir Crit Care Med; 2011 Jul; 184(1):132-40. PubMed ID: 21493734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct Detection by the Xpert MTB/RIF Assay and Characterization of Multi and Poly Drug-Resistant Tuberculosis in Guinea-Bissau, West Africa.
    Rabna P; Ramos J; Ponce G; Sanca L; Mané M; Armada A; Machado D; Vieira F; Gomes VF; Martins E; Colombatti R; Riccardi F; Perdigão J; Sotero J; Portugal I; Couto I; Atouguia J; Rodrigues A; Viveiros M
    PLoS One; 2015; 10(5):e0127536. PubMed ID: 26017968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the utility of Xpert(®) MTB/RIF as a screening tool for patients admitted to medical wards in South Africa.
    Heidebrecht CL; Podewils LJ; Pym AS; Cohen T; Mthiyane T; Wilson D
    Sci Rep; 2016 Jan; 6():19391. PubMed ID: 26786396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A meta-analysis of drug resistant tuberculosis in Sub-Saharan Africa: how strongly associated with previous treatment and HIV co-infection?
    Berhan A; Berhan Y; Yizengaw D
    Ethiop J Health Sci; 2013 Nov; 23(3):271-82. PubMed ID: 24307827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study.
    Lawn SD; Brooks SV; Kranzer K; Nicol MP; Whitelaw A; Vogt M; Bekker LG; Wood R
    PLoS Med; 2011 Jul; 8(7):e1001067. PubMed ID: 21818180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.